C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/63 (2006.01) C12N 15/10 (2006.01) C12N 15/64 (2006.01) C12N 15/65 (2006.01) C12N 15/66 (2006.01)
Patent
CA 2226463
Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
Afin de mettre en oeuvre le clonage de recombinaison décrit, on utilise des acides nucléiques, des vecteurs et des procédés in vitro et in vivo pour déplacer ou échanger des segments de molécules d'ADN au moyen de sites et de protéines de recombinaison obtenus par génie génétique, et obtenir des molécules chimériques d'ADN qui ont la ou les caractéristique(s) et/ou le ou les segment(s) d'ADN voulus.
Brasch Michael A.
Hartley James L.
Life Technologies Inc.
Life Technologies Corporation
Mbm Intellectual Property Law Llp
LandOfFree
Recombinational cloning using engineered recombination sites does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinational cloning using engineered recombination sites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinational cloning using engineered recombination sites will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1867348